O'Keefe Stevens Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Buy
13,724
+512
+4% +$41.3K 0.22% 43
2026
Q1
$1.14M Buy
13,212
+1,125
+9% +$108K 0.28% 41
2025
Q4
$1.16M Buy
12,087
+721
+6% +$70K 0.3% 35
2025
Q3
$1.08M Buy
11,366
+248
+2% +$22.8K 0.29% 37
2025
Q2
$969K Buy
11,118
+1,651
+17% +$140K 0.27% 39
2025
Q1
$851K Buy
9,467
+2,007
+27% +$180K 0.28% 39
2024
Q4
$596K Buy
7,460
+2,031
+37% +$176K 0.18% 43
2024
Q3
$489K Buy
5,429
+1,628
+43% +$137K 0.15% 47
2024
Q2
$299K Buy
3,801
+1,264
+50% +$104K 0.1% 52
2024
Q1
$221K Buy
+2,537
New +$217K 0.07% 59

Other funds holding MDT

O'Keefe Stevens Advisory's MDT Position: Q2 2026 in Review

O'Keefe Stevens Advisory increased its Medtronic (MDT) stake by 3.9% in Q2 2026, buying an estimated $41.3K and bringing the position to 13,724 shares worth $1.07M. The position accounts for 0.22% of the portfolio, ranked #43.

O'Keefe Stevens Advisory first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.16M in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • O'Keefe Stevens Advisory held 13,724 shares of Medtronic worth $1.07M as of Q2 2026.
  • O'Keefe Stevens Advisory bought 512 Medtronic shares in Q2 2026, an estimated $41.3K.
  • Medtronic made up 0.22% of O'Keefe Stevens Advisory's portfolio in Q2 2026, its #43 holding.
  • O'Keefe Stevens Advisory first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • O'Keefe Stevens Advisory's Medtronic position peaked at $1.16M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q2 2026, filed 13 Jul 2026.